Mayo Clinic Research

Rochester, Minnesota 559050002

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease

Studies at this site

• Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease — Completed
• Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed